StockMarketWire.com - Respiratory diseases focused Synairgen said it had appointed Gareth Walters to the newly created role of chief regulatory officer.

The appointment had been made in preparation for regulatory submissions for SNG001, a treatment for Covid-19.

Walters previously was global regulatory affairs head at Chugai Pharmaceuticals.


Story provided by StockMarketWire.com